Ask Mallard

The minimal clinically important difference

The minimal clinically important difference is the smallest change in an outcome that a patient would perceive as beneficial and that would justify a change in management.

Why it is needed

Statistical significance says a difference is unlikely to be chance; it says nothing about whether the difference is worth having. In a large trial a change of no consequence to anyone will be significant, and in a small trial an important one will not be. The MCID supplies the missing scale.

How it is derived

  • ANCHOR-based: relate the change in score to an external judgement, usually the patient's own global rating of whether they are better, and read off the score change corresponding to a small but noticeable improvement.
  • DISTRIBUTION-based: use a fraction of the standard deviation or the standard error of measurement. These describe what change can be reliably detected, not what change matters.
  • Consensus among clinicians or patients, which is transparent and subjective.
  • The best evidence combines an anchor-based estimate with a distribution-based floor, since a difference smaller than the measurement error cannot be claimed anyway.
  • The value should come from a population resembling the study's, and be cited.

Where it is used

In sample size calculation, as the difference the study should be able to detect. In interpreting a confidence interval: an interval lying entirely below the MCID rules out an important effect, which is a positive finding rather than a null one. And in noninferiority trials, where the margin is a version of the same judgement.

Group and individual are different

The MCID was defined for individual change, and a group mean difference of that size means something else: it can arise from most people unchanged and a minority improving a lot. Reporting the proportion of patients exceeding the threshold, alongside the mean difference, addresses this directly.

What to watch out for

There is no single MCID for an instrument: published values for the same scale differ by a factor of two or more, because they depend on the population, the direction of change, the baseline severity and the method used to derive them. Distribution-based values, half a standard deviation and the like, are statements about measurement precision rather than about what patients care about, and using one as if it were an anchor-based value confuses the two.

Clinical example

A trial finds a mean improvement of 2.1 points on a symptom scale, p equal to 0.01, where the anchor-based MCID is 5 points. The result is real and too small to matter, and the confidence interval excluding 5 is the sentence worth writing.

Recent studies that used this
Searching PubMed…
Related Learn pages
Sources & further reading
  1. Measurement of health status. Ascertaining the minimal clinically important difference (opens in a new tab) · Control Clin Trials · doi 10.1016/0197-2456(89)90005-6
  2. Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension (opens in a new tab) · JAMA · doi 10.1001/jama.2013.879
The second reference is a reporting guideline, cited here because it requires trials using patient-reported outcomes to state how their results should be interpreted, which is where a minimal important difference belongs.
Last source review: 2026-09-06
AI-generated educational content
Mallard uses reputable methodological and reporting sources, but this material may contain errors or omit important context. Verify important methodological decisions with the cited sources and, when appropriate, a qualified research methodologist or statistician.